Avid Radiopharmaceuticals' Series C Round

Avid Radiopharmaceuticals raised a round of funding on May 04, 2007.

Avid is a clinical-stage product-focused molecular imaging company with IP in the field of molecular brain imaging. Per the company, Avid has developed targeting agents to image amyloid plaques and a…

Articles about Avid Radiopharmaceuticals' Series C Round: